single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients a systematic review单一药物疗法或选择性净化消化道的预防性抗真菌治疗危重病人系统回顾.pdfVIP

下载本文档

2
0
约10.5万字
约 16页
2017-09-12 发布于上海
举报
版权申诉

single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients a systematic review单一药物疗法或选择性净化消化道的预防性抗真菌治疗危重病人系统回顾.pdf

1、有哪些信誉好的足球投注网站（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients a systematic review单一药物疗法或选择性净化消化道的预防性抗真菌治疗危重病人系统回顾

Available online /content/11/6/R126 Vol 11 No 6 Open Access Research Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review 1 1 1 1 2 JW Olivier van Till , Oddeke van Ruler , Bas Lamme , Roy JP Weber , Johannes B Reitsma and Marja A Boermeester1 1Department of Surgery, Academic Medical Center, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands 2Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Room J1b-208, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands Corresponding author: Marja A Boermeester, m.a.boermeester@amc.uva.nl Received: 26 Jun 2007 Revisions requested: 2 Aug 2007 Revisions received: 16 Aug 2007 Published: 7 Dec 2007 Critical Care 2007, 11:R126 (doi:10.1186/cc6191) This article is online at: /content/11/6/R126 © 2007 van Till et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Introduction The objective of this study was to determine and OR 0.54, 95% CI 0.39 to 0.75; SDD: OR 0.29, 95% CI 0.18 to compare the effectiveness of different prophylactic antifungal 0.45). Treatment effects were significantly larger in SDD trials therapies in critically ill patients on the incidence of yeast than in SAP trials. The incidence of candidemia was reduced by colonisation,